Ekso Bionics Holdings, Inc. (LON:0IFR)

Market Cap	6.95M
Revenue (ttm)	14.32M
Net Income (ttm)	-9.05M
Shares Out	n/a
EPS (ttm)	-0.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	670
Average Volume	2,652
Open	0.3762
Previous Close	0.3902
Day's Range	0.3727 - 0.3993
52-Week Range	0.4861 - 2.3814
Beta	1.88
RSI	31.59
Earnings Date	Apr 28, 2025

About Ekso Bionics Holdings

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot ort...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2005
• Employees: 66
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IFR

Financial Performance

In 2024, Ekso Bionics Holdings's revenue was $17.93 million, a decrease of -1.94% compared to the previous year's $18.28 million. Losses were -$11.33 million, -25.45% less than in 2023.

Financial numbers in USD